Agilent Technologies Inc - Company Profile
Powered by
All the data and insights you need on Agilent Technologies Inc in one report.
- Save hours of research time and resources with
our up-to-date Agilent Technologies Inc Strategy Report
- Understand Agilent Technologies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Agilent Technologies Inc (Agilent) is a provider of analyzing instruments, reagents, and consumables for laboratory processes. It also offers allied software and services. The company is primarily focused on scientific research, patient diagnostics, and safety testing for water, food, and pharmaceuticals. Its product portfolio includes mass spectrometry, microarray solutions, flow cytometry, vacuum technologies and others. Agilent caters to varied industries, including contract research organizations (CROs), contract manufacturing organizations (CMOs), pharmaceuticals, diagnostics, applied materials, and chemicals. The company has a significant presence across the world, with sales offices, logistics centers, R&D centers and business facilities. It commercializes its products through a network of direct sales agents, distributors, resellers, manufacturers' representatives and electronic commerce. Agilent is headquartered in Santa Clara, California, the US.
Agilent Technologies Inc premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Analytical Instruments and Supplies: | CrossLab Instrument | AccuScript |
Chromatography | Service and Repair | AdvanceBio |
Mass Spectrometry | Compliance | AffinityScript |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In January, the company entered an agreement with Incyte to develop and commercialize companion diagnostics for Incyte's hematology and oncology products. |
2024 | New Products/Services | In January, the company introduced the Agilent ProteoAnalyzer system. |
2023 | Regulatory Approval | In November, the company received approval from the FDA for the use of PD-L1 IHC 22C3 pharmDx as a diagnostic tool to aid in identifying patients with Gastric or Gastroesophageal Junction Adenocarcinoma. |
Competitor Comparison
Key Parameters | Agilent Technologies Inc | Thermo Fisher Scientific Inc | Abbott Laboratories | Danaher Corp | Illumina Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Santa Clara | Waltham | Abbott Park | Washington | San Diego |
State/Province | California | Massachusetts | Illinois | WashingtonD.C. | California |
No. of Employees | 17,700 | 122,000 | 114,000 | 61,000 | 10,590 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Mike McMullen | Chief Executive Officer; President; Director | Executive Board | 2015 | 61 |
Robert W. McMahon | President - Diagnostics and Genomics Group - Interim; Chief Financial Officer; Senior Vice President | Senior Management | 2018 | 54 |
Katharine Knobil | Chief Medical Officer | Senior Management | 2021 | - |
Padraig McDonnell | President - Agilent CrossLab Group; Senior Vice President; Chief Commercial Officer | Senior Management | 2021 | - |
Rodney Gonsalves | Principal Accounting Officer; Vice President; Corporate Controller | Senior Management | - | 57 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward